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T cell receptor (TCR) cross-reactivity between major
histocompatibility complex II (MHCII)-binding self
and foreign peptides could influence the naive
CD4+ T cell repertoire and autoimmunity. We found
that nonamer peptides that bind to the same MHCII
molecule only need to share five amino acids to
cross-react on the same TCR. This property was bio-
logically relevant because systemic expression of a
self peptide reduced the size of a naive cell popula-
tion specific for a related foreign peptide by deletion
of cells with cross-reactive TCRs. Reciprocally, an
incompletely deleted naive T cell population specific
for a tissue-restricted self peptide could be triggered
by related microbial peptides to cause autoimmu-
nity. Thus, TCR cross-reactivity between similar
self and foreign peptides can reduce the size of
certain foreign peptide-specific T cell populations
and might allow T cell populations specific for tis-
sue-restricted self peptides to cause autoimmunity
after infection.
INTRODUCTION
Naive T cell populations vary in size over several orders ofmagni-
tude (Alanio et al., 2010; Campion et al., 2014; Flesch et al., 2010;
Kotturi et al., 2008; Kwok et al., 2012; Legoux et al., 2010; Moon
et al., 2007; Obar et al., 2008; Schmidt et al., 2011; Su et al.,
2013; Tan et al., 2011). It remains unclear, however, which
factors account for this variability. The chemistry of the interac-
tion between certain major histocompatibility complex bound
peptides (p:MHC) and the T cell antigen receptor (TCR) is one
important determinant (Chu et al., 2010; Turner et al., 2005).
Alternatively, foreign-p:MHC-specific T cell populations with a
high degree of cross-reactivity for self-p:MHC encountered dur-
ing thymic development might be pared by negative selection.This possibility, however, has been difficult to assess because
the rules for TCR cross-reactivity have not been determined.
Recent progress, however, has been made in this area for
p:MHCII-specific TCRs expressed by CD4+ T cells (Birnbaum
et al., 2014; Lucca et al., 2014; Su et al., 2013). Peptides of up
to 20 amino acids bind to MHCII molecules via a nine amino
acid core sequence (Rudolph et al., 2006). Certain amino acids
within the core nonamer, often at positions 1, 4, 6, and 9, anchor
the peptide by fitting into discrete pockets in the MHCII groove
(Painter and Stern, 2012). The amino acids at positions 2, 3, 5,
and 8 generally point up and out of the MHCII binding groove.
Complementarity determining region (CDR) 1 and 2 of the TCR
interact with the MHCII molecule, whereas CDR3 interacts
mainly with the upward pointing residues in the peptide (Marrack
et al., 2008). Using soluble TCRs to probe yeast-displayed
MHCII-bound peptide libraries, Birnbaum et al., (2014) found
that a single TCR could bind dozens of peptides with similar
TCR contact amino acids but very different MHCII anchor amino
acids. If TCR specificity is determined by only 4 of the 9 amino
acids in a peptide, then 1 in 160,000 (204) MHCII-bound peptides
will have the same TCR contact amino acids and thus bind to the
same TCR. Because a mammalian proteome can theoretically
produce many more than 160,000 different MHCII-binding pep-
tides, any one MHCII-bound foreign peptide could have several
self-peptide homologs. These homologs could reduce the size of
foreign peptide-specific populations by causing clonal deletion.
Because different foreign peptides could have different numbers
of self-peptide homologs, the corresponding naive cell popula-
tions could undergo different degrees of selection and vary in
size for this reason.
We tested this premise in C57BL/6 (B6) mice, which express
the I-Ab MHCII molecule. We confirmed that TCR specificity for
peptides bound to I-Ab (p:I-Ab) depended primarily on five TCR
contact amino acids andwas relatively independent of the nature
of the MHCII anchor residues. This type of TCR cross-reactivity
reduced the size of T cell populations specific for foreignpeptides
that had many self-peptide homologs. In addition, an incom-
pletely deleted naive population specific for a tissue-restricted
self peptide could be primed with I-Ab-bound bacterial peptides
that matched the self peptide at TCR contact amino acids. Thus,Immunity 42, 95–107, January 20, 2015 ª2015 Elsevier Inc. 95
Table 1. Sequence of Peptides in I-Ab Tetramers
Peptide Sequence
ESAT6 QQWNFAGIEAAASA
FliC VQNRFNSAITNLGNT
STM1540-3# VYYTTYAPQAT
STM1540-1# YTTYAPQATSA
eGFP HDFFKSAMPEGYVQE
OVA3C# GHAAHAEINEA
RplF FVSPAAHII
OVA2C# QAVHAAHAEIN
3K EAQKAKANKAVDKA
Calnexin LVVKNPAAHHAIS
AasF VSSPAVQES
1G1W EAGGALANWAVDSA
LLO# NEKYAQAYPNVS
Derp1 CQIYPPNVNKI
Cda2 HQYMTALSNEVVF
PmpG-1 YVDPAAAGG
CTB NNKTPHAIAAIS
GP66 DIYKGVYQFKSV
2W EAWGALANWAVDSA
CD4Ag28m VEIHRPVPGTA
2W109# EYWGPLPNWV
MOG# GWYRSPFSRVVVHLY
Each amino acid sequence contained in an I-Ab tetramer used in this
study is listed. The underlined sequences indicate the nonamer core
predicted by Zhu et al. (2003) and Liu et al. (2002) for each peptide.
The # signs refer to peptides that were locked into the I-Ab molecule in
the indicated register by a disulfide trap strategy (Stadinski et al.,
2010). The ESAT6 peptide is from the ESAT6 protein of Mycobacterium
tuberculosis (Reiley et al., 2010); the FliC, STM1540-3, and STM1540-1
peptides are from the flagellin or STM1540 proteins of Salmonella enter-
ica serovar Typhimurium (Maybeno et al., 2012; McSorley et al., 2000);
the OVA2C and OVA3C peptides are from chicken ovalbumin (Moon
et al., 2011; Robertson et al., 2000); the RpIF, Aasf, and PmpG-1 peptides
are from ribosomal protein L6, anti-anti-sigma factor, and polymorphic
membrane protein G of Chlamydia muridarum (Li and McSorley, 2013);
the LLO peptide is from the listeriolysin O protein of Listeria monocyto-
genes (Geginat et al., 2001; Pepper et al., 2011); the CTB peptide is
from the cholera toxin B subunit of Vibrio cholerae (Cong et al., 1996);
the GP66 peptide is from glycoprotein 1 of Lymphocytic choriomeningitis
virus (Oxenius et al., 1995); the CD4Ag28m peptide is from a putative
transmembrane protein of Toxoplasma gondii (Grover et al., 2012); the
Derp1 peptide is from the Der fI protein of Dermatophagoides farinae
(Hoyne et al., 1994); the MOG peptide is frommouse myelin oligodendro-
cyte glycoprotein (Mendel et al., 1995); the calnexin peptide is from the
calnexin protein of Blastomyces dermatitidis; the Cda2 peptide is from
the chitin deacetylase 2 protein of Cryptococcus neoformans; and the
eGFP peptide is from enhanced green fluorescent protein. The 2W
(Rees et al., 1999), 3K (Rees et al., 1999), 2W109, and 1G1W (Chu
et al., 2010) peptides are variants of the E alpha peptide from the I-E
MHCII molecule (Murphy et al., 1992).TCRcross-reactivity between similar self and foreign peptides in-
fluences the composition of the foreign peptide-specific T cell
repertoire via clonal deletion and accounts for the capacity of mi-
crobial peptides to trigger autoimmunity to a self peptide.96 Immunity 42, 95–107, January 20, 2015 ª2015 Elsevier Inc.RESULTS
Foreign-p:I-Ab-Specific Naive T Cell Populations Vary
in Size
Naive CD4+ T cell populations specific for three different I-Ab-
bound foreign (non-mouse) peptides vary in size in B6 mice
(Moon et al., 2007). We enumerated many more populations to
estimate the normal range and to set the stage for assessment
of the effect of clonal deletion by related self (mouse) peptides.
A p:MHCII tetramer-based cell enrichment and flow cytometry
strategy (Moon et al., 2007, 2009) was used to identify naive
CD4+ T cell populations in B6 mice specific for the first 20
different I-Ab-bound foreign peptides listed in Table 1. In each
case, cells from the secondary lymphoid organs were stained
with a pair of I-Ab tetramers containing the same peptide but
labeled with different fluorochromes to maximize the TCR spec-
ificity of the assay (Stetson et al., 2002; Tubo et al., 2013).
Tetramer-bound cells were then labeled with magnetic beads,
enriched on magnetized columns, and stained with antibodies
specific for informative surface markers. The tetramer-bound
cells in the bound fraction were detected by gating on lympho-
cyte-sized single cells that expressed CD90.2 but not B220,
CD11b or CD11c, and CD4, but not CD8 (Figure 1A). Most dou-
ble tetramer-binding cells had the CD44lo phenotype of naive
cells, indicating that these mice, which were housed in a specific
pathogen-free facility, had no prior exposure to these epitopes
(Figure 1B, left columns). The absolute number of naive CD4+
cells ranged from fewer than an average of 5 ESAT6:I-Ab+ cells
per mouse to over 500 CD4Ag28m:I-Ab+ cells per mouse (Fig-
ure 1C, filled circles).
Mice were then immunized with the 20 peptides emulsified in
complete Freund’s adjuvant (CFA) to test the hypothesis that
naive cell number predicts the magnitude of the effector cell
response (Jenkins and Moon, 2012). Immunization caused the
relevant p:I-Ab-specific T cells to expand and induce CD44
expression 2 weeks after immunization (Figure 1B, right col-
umns). The number of effector cells corresponded to the number
of naive cells in most cases (Figure 1C). Naive cell number pre-
dicted 64% of the variance in the number of effector cells gener-
ated in response to peptide immunization across the 20 CD4+
T cell populations (Figure 1D).
The interferon-g Enzyme-Linked ImmunoSpot (ELISPOT)
assay (Streeck et al., 2009) was then used to confirm the effector
cell population size measurements with a test that did not
depend on tetramer binding. B6 mice were immunized with a
pool of 19 peptides emulsified in CFA. Two weeks later, the
spleen and lymph nodes from individual mice were assayed
by p:I-Ab tetramer-based cell enrichment or ELISPOT. A highly
significant correlation was observed between the numbers
of effector cells in the p:I-Ab-specific populations detected
by each assay (Figure 1E). This result validated the use of
tetramer-based cell enrichment to measure the sizes of p:I-Ab-
specific populations and solidified the conclusion that the
magnitude of the effector cell response is related to the size of
the relevant naive cell population. The lack of a perfect correla-
tion between naive and effector cell numbers, however, indi-
cates that other factors influence the magnitude of the primary
immune response such as how well or long a peptide binds
MHCII or engages regulatory T cells (Sant et al., 2013).
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Determining the TCR Contact Amino Acids in Nonamer
Core Peptides
To determine whether clonal deletion based on TCR cross-reac-
tivity contributed to the variation in naive population size, it was
necessary to identify the TCR contact amino acids in the foreign
peptides. An I-Ab peptide-binding motif (Liu et al., 2002; Zhu
et al., 2003) was used to identify the most likely nonamer cores
for the foreign peptides shown in Table 1. It was not necessary
to identify the core for five of the peptides, because they were
locked into the I-Ab molecule in the register shown in Table 1
using a disulfide trap strategy (Stadinski et al., 2010).
If the I-Ab binding nonamer cores shown in Table 1 are correct,
then P5 should be the most important amino acid for TCR recog-
nition because the CDR3s of TCRs generally interact with this
amino acid (Marrack et al., 2008). Sets of 11 peptides, each 11
amino acids long and containing an alanine substitution at P-1
to P10, were prepared for each of 13 I-Ab-binding foreign parent
peptides to test this possibility. All alanine-substituted peptides
were predicted to bind I-Ab because alanine is a favorable resi-
due for all of the pockets in this MHCII molecule (Liu et al.,
2002; Zhu et al., 2003). Eleven amino acid peptides were used
because it was not clear whether amino acids flanking the non-
amer core could serve as additional TCR contacts (Huseby et al.,
2005). Mice were primed with the parent peptides in CFA, and
2 weeks later, CD4+ T cells from the draining lymph nodes
were stimulated with the parent peptide used for priming or the
alanine substituted peptides. The T cell response was then
measured by ELISPOT. Alanine substitutions at the predicted
P5 residues reduced reactivity by parent peptide-primed
T cells by an average of 90% (Figure 2A). Substitutions at P2
or P8 also reduced T cell reactivity by at least 65% as predicted
for TCR contact residues (Huseby et al., 2005). In contrast, sub-
stitutions at P1 or P9, as well as the flanking amino acids,
reduced T cell reactivity on average less than 30%. These results
are consistent with P2, 5, and 8 being TCR contact residues for
these I-Ab-bound peptides.
Substitutions at I-Ab anchor residues P4, 6, and 7 reduced
reactivity by parent peptide-primed T cell populations by at least
50%. Because there was some variability in the effect of alanine
substitution across the 13 peptides as evidenced by the large
standard deviations in Figure 2A, an unsupervised clustering of
the alanine scan data was performed as an independent way
to identify the important TCR contacts (Figure 2B). P2, 5, and 8
clustered and had the largest effects on TCR recognition. P7
was also in this cluster. P3, 4, and 6 formed another cluster
with smaller effects, while P-1, 1, 9, and 10 clustered for the
smallest effects on TCR specificity. On the basis of these results,Figure 1. Relationship between p:I-Ab-Specific CD4+ T Cell Population
(A) Gates used to identify lymphocyte-sized, non-doublet, CD90.2+ B220 CD11
(B) Contour plots of double tetramer staining (far left) or CD44 expression (left) fo
unimmunized B6 mice following enrichment with the indicated p:I-Ab tetramers lab
right represent similar staining for populations in spleen and draining lymph no
emulsified in CFA.
(C) Total number of tetramer-binding CD4+ T cells per mouse for I-Ab-bound pept
identified as in (B). Horizontal bars indicate mean values. The depicted results w
(D) Linear correlation between the average log10 naive and effector cell number f
(E) Linear correlation between the average log10 effector cell number obtained b
injection of 19 peptides from (C) emulsified in CFA. The depicted results were fro
peptide for the tetramer enrichment assay and the mean of two values from indi
98 Immunity 42, 95–107, January 20, 2015 ª2015 Elsevier Inc.it is likely that P2, 5, 7, and 8 are the main TCR contacts for I-Ab-
bound peptides. P7 might serve as both a TCR contact and an
I-Ab anchor because it occupies a shallow pocket allowing its
side chain to protrude for recognition by TCRs (Zhu et al.,
2003). P3 might also be in this category. P4 and P6 could have
affected TCR specificity indirectly by altering the positions of
the upward pointing residues because it is likely that P4 and
P6 are buried in the I-Ab molecule (Zhu et al., 2003) and thus un-
available for direct interaction with the TCR.
TCRContact Amino Acid Conservation Predicts p:MHCII
Cross-Reactivity within Polyclonal CD4+ T Cell
Populations
The knowledge that P2, 5, 7, and 8 are themain TCR contacts for
I-Ab-bound peptides made it possible to test the limits of TCR
cross-reactivity in this system. Over 1,000 bacterial proteomes
were searched for predicted I-Ab-binding nonamer peptides
(Zhu et al., 2003) that matched immunogenic peptides from lis-
teriolysin O (LLO) of Listeria monocytogenes, glycoprotein 1 of
Lymphocytic choriomeningitis virus (GP66), or 3K or 2W variants
of an MHCII peptide at P2, 5, 7, and 8 but at most one of the P1,
4, 6, or 9 residues. Three such peptides were selected for 3K, 1
for LLO, 4 for GP66, and 5 for 2W. B6micewere then primedwith
the parent peptides or the corresponding variant peptides, and
the number of responding CD4+ T cells was measured with
3K:I-Ab, LLO:I-Ab, GP66:I-Ab, or 2W:I-Ab tetramers. Mice primed
11 days earlier with 3K, LLO, GP66, or 2W peptides in CFA but
not CFA alone had large populations of CD44hi tetramer-binding
cells (Figure 3A). One of 3 3K, 1 of 1 LLO, 2 of 4 GP66, and 4 of 5
2W variant peptides caused expansion of CD44hi CD4+ T cells
capable of binding the relevant parent tetramer (Figure 3B).
Thus, 8 of 13 (62%) I-Ab-binding peptides sharing 4 TCR contact
amino acids but at most one I-Ab anchor residue exhibited TCR
cross-reactivity.
Self p:MHCII Cross-Reactivity Limits Naive Population
Size and Responsiveness to Homologous Foreign-
p:MHCII
The results raised the possibility that TCR cross-reactivity be-
tween self and foreign peptides could lead to reductions in the
sizes of foreign peptide-specific naive populations because of
clonal deletion. To determine whether this phenomenon could
occur, we examined Act-2W transgenic mice that express 2W
as a self peptide under the control of the actin promoter (Moon
et al., 2011) for the presence of T cells specific for a related pep-
tide called 2W109, which has the same amino acids as 2W at P2,
3, 5, 7, and 8 but different residues at P1, 4, 6, and 9 (Table 1,Sizes in Unimmunized and Immunized Mice
b CD11c, CD4+ T cells.
r CD4+ T cells from spleen and lymph nodes identified as in (A) from individual
eled with streptavidin-PE (x axis) or streptavidin-APC (y axis). The plots on the
des 14 days after subcutaneous injection with 10 mg of the relevant peptide
ides in individual unimmunized (open circles) or immunized (filled circles) mice
ere pooled from 11 independent experiments.
or each of the populations identified in (C).
y tetramer staining (x axis) or ELISPOT (y axis), 14 days after subcutaneous
m one experiment with the mean of three values from individual mice for each
vidual mice for the ELISPOT assay.
AB
Figure 2. Alanine Substitution Analysis of CD4+ T Cell Responses to
Known Foreign Epitopes
(A) Eleven amino acid versions of the indicated peptides (nonamer cores
shown in Table 1 plus P-1 and P10, nonamer core WFPAEPEDV for Cre) with
single alanine substitutions at the indicated positions were tested as stimu-
lators of parent peptide-primed CD4+ T cells in an ELISPOT assay. The per-
centage of the response to the parent peptide was determined by dividing the
number of spots stimulated by the alanine substituted peptide by the number
of spots stimulated by the parent peptide and multiplying by 100. The bars
represent the average (±SD, n = 3 mice) values for the parent peptides shown
in (B) from two independent experiments.
(B) Unsupervised clustering of the percentage of response to the parent
peptide after stimulation with alanine-substituted peptides for each of the 13
indicated parent peptides.Figure 4A). B6 mice had on average 1,000 2W109:I-Ab-specific
naive CD4+ T cells. In contrast, Act-2W mice contained a
mean of 400 2W109:I-Ab-reactive cells (Figure 4B), suggesting
that 600 2W109:I-Ab-specific cells were deleted in response
to recognition of 2W:I-Ab. This difference was specific to
2W109:I-Ab because both strains had the same number of
LLO:I-Ab-specific naive cells (Figure 4B).Simultaneous staining with 2W:I-Ab and 2W109:I-Ab tetra-
mers was then performed to directly assess TCR cross-reac-
tivity as the basis for the smaller 2W109:I-Ab-specific
population in Act-2W mice. B6 mice contained 260 naive cells
that bound 2W:I-Ab alone and this number was reduced
by about half to 140 cells in Act-2W mice (Figure 4C) as
previously described (Moon et al., 2011). In contrast, the num-
ber of cells in B6 and Act-2W mice that were specific for
2W109:I-Ab alone, 700 and 560 respectively was not signifi-
cantly different. B6 mice also contained cells that bound both
2W:I-Ab and 2W109:I-Ab tetramers, proving the existence of
TCRs that were cross-reactive on these p:I-Ab complexes. B6
mice contained a mean of 180 of these cells, while Act-2W
mice contained only 40. By this method, 880 2W109:I-Ab-
specific cells were detected in B6 mice and 600 in Act-2W
mice, suggesting the loss of 280 cells in the latter strain. This
reduction was smaller than the difference of 600 2W109:I-Ab-
specific observed in B6 and Act-2W mice after staining with
2W109:I-Ab tetramer alone (Figure 4B). This discrepancy
could have been related to under detection of targets due to
competition between the 2W:I-Ab and 2W109:I-Ab tetramers
or an inability to exclude false positive events in the single
tetramer-binding populations. In any case, these results
demonstrated that B6 mice had two populations of 2W109:I-
Ab-specific T cells, one that was cross-reactive on 2W:I-Ab
and one that was not. The cross-reactive population was elim-
inated in Act-2W mice, leaving the population that was only
specific for 2W109:I-Ab.
We next determined why the 2W109:I-Ab-specific cells that re-
mained in Act-2W mice were not deleted. One possibility was
that the shared TCR contact amino acids of I-Ab-bound 2W
and 2W109 adopt slightly different conformations, and the
T cells that remained in Act-2W mice were specific for the
2W109 but not the 2W conformation. If so, then the 2W109:I-
Ab-specific cells in Act-2W mice would be expected to be
more sensitive to substitutions at I-Ab anchor positions than
2W109:I-Ab-specific cells in B6 mice. The reactivity of
2W109:I-Ab-specific CD4+ T cells in B6 mice was reduced by
at least 50% when stimulated with peptides containing alanine
substitutions at P-1, 2, 5, or 8 (Figure 4E, black bars). In contrast,
the reactivity of the 2W109:I-Ab-specific population in Act-2W
mice was reduced by at least 50% when stimulated with pep-
tides containing substitutions at P-1, 1, 2, 3, 4, 5, 6, 7, or 8 (Fig-
ure 4E, white bars). Thus, the 2W109:I-Ab-specific population
that survived negative selection in the presence of 2W:I-Ab
appeared to be specific for TCR contact amino acids in an I-Ab
anchor residue-dependent fashion.
The unusual sensitivity of 2W109:I-Ab-specific T cells in Act-
2Wmice to I-Ab anchor substitutions suggested that this feature
might be useful for identifying other foreign peptide-specific
T cell populations that experienced clonal deletion. Indeed, small
foreign peptide-specific populations tended to more sensitive to
substitutions at I-Ab anchors P1, 4, 6, and 7 than large popula-
tions (Figure 4F).
A search was then performed for self-peptide homologs that
could have contributed to deletion of clones from each of the
foreign p:I-Ab-specific CD4+ T cell populations. A bioinformatic
screen was developed to identify mouse peptides that were pre-
dicted to bind I-Ab and share TCR contact amino acids with theImmunity 42, 95–107, January 20, 2015 ª2015 Elsevier Inc. 99
AB
C
D
44
100 101 102 103 104 105
(2W) AWGALANWA
R. palustris IWPPLVNWA
X. albilineans YWSVLPNWA
H. ducreyi PWQPLANWY
M. adhaerens FWEKLANWV
D. acetoxidans FWLPLSNWA
No peptide
(GP66) YKGVYQFKS
L. byssophila YKGTYPFKN
Z. galactanivorans YKDSYPFKE
L. amylovorus YKWTYPFKA
L. lactis YKLPYSFKR
No peptide
(LLO) YAQAYPNVS
A. mobile FAQSYPNVV
No peptide
(3K) AQKAKANKA
 V. cholerae NQKPKANKP
M. odoratimimus YQKVKANKG
 C. aggregans AQKPKPNKQ
No peptide 2W:I-A
b+
LLO:I-Ab+
GP66:I-Ab+
3K:I-Ab+
p:I-Ab+ cells
Priming
LLO:I-Ab
(LLO) 
YAQAYPNVS
A. mobile
FAQSYPNVVNo peptide
0
102
103
104
105
0 102 103 104 105 0 102 103 104 105 0 102 103 104 105
0
102
103
104
105
0
102
103
104
105
0 102 103 104 105
3K:I-Ab
(3K) 
AQKAKANKA
M. odoratimimus
YQKVKANKGNo peptide
0 102 103 104 105 0 102 103 104 105
0
102
103
104
105
0
102
103
104
105
0
102
103
104
105
GP66:I-Ab
(GP66) 
YKGVYQFKS
L. byssophila
YKGTYPFKNNo peptide
0 102 103 104 105 0 102 103 104 105 0 102 103 104 105
0
102
103
104
105
0
102
103
104
105
0
102
103
104
105
2W:I-Ab
(2W) 
AWGALANWA
X. albilineans
YWSVLPNWANo peptide
0 102 103 104 105 0 102 103 104 105 0 102 103 104 105
0
102
103
104
105
0
102
103
104
105
0
102
103
104
105
Figure 3. Conservation of TCR Contact Amino Acids Predicts p:I-Ab Cross-Reactivity
(A) Contour plots showing parent p:I-Ab tetramer staining (indicated on the x axes) of spleen and lymph node cells frommice primed 11 days earlier with CFA alone
(no peptide), homologous bacterial peptide, or parental peptide. CD44hi tetramer-binding cells are indicated in the rectangular gates.
(B) Average number of 3K:I-Ab+, LLO:I-Ab+, GP66:I-Ab+, or 2W:I-Ab+ CD4+ T cells 11 days after priming with the indicated peptides emulsified in CFA (±SEM, n = 3
mice) from 1 experiment, which was representative of another.foreign peptides shown in Table 1 (Figure S1). The stringency of
the search was reduced to include any combination of 4 out of 5
identical amino acid residues at P2, 3, 5, 7, and 8 to capture any
self peptide that could have an effect. Mouse-peptide homologs
were identified for all the foreign peptides, with a range of 3 to
183 (Table S1). A significant inverse correlation was observed
between naive CD4+ T cell population size and the number of
self-peptide homologs (Figure 4G), although the r2 value was
only 0.27. These results support the conclusion that TCR
cross-reactivity on self-peptide homologs plays some role in
determining the size of MHCII-bound foreign peptide-specific
CD4+ T cell populations.
Small Foreign p:MHCII-Specific T Cell Populations
Contain Cells with Low-Affinity TCRs
The relatively weak correlation in Figure 4G spurred a search for
additional evidence that clonal deletion sculpts naive CD4+ T cell100 Immunity 42, 95–107, January 20, 2015 ª2015 Elsevier Inc.population size. Earlier work indicated that self p:MHCII-specific
T cells that survived clonal deletion bound tetramer poorly due to
expression of low-affinity TCRs (Moon et al., 2011; Zehn and
Bevan, 2006). On the basis of this observation, we determined
whether tetramer binding intensity could be used to identify
foreign p:MHCII-specific populations that experienced clonal
deletion on a related self p:MHCII ligand. Indeed, as shown in
Figure 5A, 2W109:I-Ab-specific naive T cells in Act-2W mice
bound 2W109:I-Ab tetramer less well than the comparable
population in B6 mice. This difference was not observed for
LLO:I-Ab-specific T cells in these strains, indicating that it re-
sulted as a consequence of 2W:I-Ab complexes in Act-2W
mice. Thus, clonal deletion on a self p:MHCII ligand produced
a smaller and lower-affinity population of T cells specific for a
related foreign p:MHCII ligand.
On the basis of this result, we determined whether the small
foreign p:MHCII-specific naive populations had this fingerprint
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Figure 4. Cross-Reactivity with Self-p:MHCII Affects Foreign-p:MHCII Cell Number
(A) Sequence alignment of 2W and 2W109 peptides.
(B) Number of 2W109:I-Ab+ or LLO:I-Ab+ CD4+ T cells in the spleen and lymph nodes of unimmunized B6 (filled circles) or Act-2W (open circles) mice, enumerated
by double tetramer staining as in Figure 1 (***p < 0.0001, n.s. = not significant). The depicted results were pooled from three independent experiments.
(legend continued on next page)
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of clonal deletion. Expanded populations of cells generated by
peptide priming were analyzed to obtain accurate quantifica-
tion of tetramer binding intensity. 2W109:I-Ab tetramer stained
the large 2W109:I-Ab-specific population more intensely than
the FliC:I-Ab tetramer stained the small FliC:I-Ab-specific popu-
lation (Figures 5B and 5C). Analysis of the populations specific
for 19 of the I-Ab-bound foreign peptides shown in Table 1 re-
vealed a highly significant correlation between the number of
cells in a given population and their tetramer binding intensity
(Figure 5D). These results indicate that small foreign p:MHCII-
specific naive populations have lost cells with the highest-affin-
ity TCRs due to deletion of clones that also recognize self
p:MHCII ligands.
A Tissue-Restricted Self p:MHCII Ligand Is Recognized
by a Large Naive T Cell Population
The results indicated that negative selection on a self-peptide
homolog could reduce the size of a foreign peptide-specific
CD4+ T cell population. We considered the corollary case in
which a self-peptide-specific CD4+ T cell population that had
not undergone complete deletion could be triggered to cause
autoimmunity by a foreign peptide with the same TCR contact
amino acids. This idea was tested with myelin oligodendrocyte
glycoprotein (MOG) peptide 40-48, which causes experimental
autoimmune encephalomyelitis (EAE) in B6 mice when injected
with CFA and pertussis toxin (Miller et al., 2010). B6 mice that
were not immunized with MOG contained about 250 MOG:I-
Ab-specific CD44lo naive CD4+ T cells (Figures 6A and 6B), which
was at the high end of the range for I-Ab-bound foreign peptides
(Figure 1B). Bacterial proteomes were then searched for pep-
tides predicted to bind I-Ab and matching MOG at P1, 2, 5, 7,
and 8 but differing at P3, 4, 6, and 9. Matching at P1 was main-
tained because alanine substitution experiments showed that P1
was critical for TCR recognition of MOG:I-Ab (data not shown).
Numerous peptides fitting the criteria were identified and three
were selected to immunize B6 mice. As shown in Figures 6C
and 6D, all three peptides induced expansion of CD44hi
MOG:I-Ab tetramer-binding T cells although not as well as
MOG itself. Two of the three bacterial peptides, the two that
stimulated the most expansion of MOG:I-Ab-specific T cells,
also caused EAE (Figure 6E). These results demonstrate that a
large naive population specific for a tissue-restricted self peptide(C) Contour plots of 2W:I-Ab streptavidin-APC (y axis) versus 2W109:I-Ab streptav
from unimmunized B6 mice following enrichment with these tetramers.
(D) Number of CD4+ T cells in the spleen and lymph nodes of unimmunized B6 (fille
left quadrants in C); 2W109:I-Ab tetramer only (bottom right quadrants in C), or b
enrichment with these tetramers (***p < 0.0005, *p < 0.05, n.s. = not significant). Th
others.
(E) Eleven amino acid versions of 2W109 peptides with single alanine substitution
T cells from B6 (filled bars) or Act-2W (open bars) mice in an ELISPOT assay. The
the number of spots stimulated by the alanine substituted peptide by the numbe
represent the average values (±SD, n = 3 mice) from three independent experim
(F) Linear regression analysis of the log10 naive cell number versus the average per
I-Ab anchor residues at P1, P4, P6, and P7. For each point, the y axis value repr
represents the mean for that peptide from Figure 2B.
(G) Linear regression analysis of the log10 naive cell number versus the number of m
Table 1 at a minimum of four out of five TCR contact positions (P2, P3, P5, P7, P
individual peptide. Spearman’s Rho test, a rank order test that makes no assum
variables (p = 0.006), which was maintained even if the population with 183 self
102 Immunity 42, 95–107, January 20, 2015 ª2015 Elsevier Inc.can be activated by bacterial-peptide homologs to induce
autoimmunity.
DISCUSSION
Work on multiple MHCII molecules has led to the conclusion
that many TCRs cross-reactive on peptides with the same sur-
face exposed amino acids but different MHCII-anchor residues
(Birnbaum et al., 2014; Lucca et al., 2014; Su et al., 2013). Our
results confirm this conclusion for the I-Ab MHCII molecule by
showing that I-Ab-binding peptides sharing four putative TCR
contact amino acids but at most one MHCII anchor amino
acid with the parent peptide were immunogenic for T cells spe-
cific for the parent peptide. In addition, we found that this type
of TCR cross-reactivity extended to negative selection as evi-
denced by the loss of cells with 2W:I-Ab and 2W109:I-Ab-spe-
cific TCRs in mice expressing the 2W peptide. These results
suggested that many TCRs focus primarily on the TCR contact
amino acids no matter how the peptide is anchored to MHCII.
This conclusion is supported by structural biology studies
showing that peptides that bind MHCII with different amino
acids but have the same upward pointing amino acids orient
those amino acids in very similar (but nonidentical) ways and
are bound with the same footprint by cross-reactive TCRs
(Birnbaum et al., 2014).
Some I-Ab-restricted TCRs could, however, distinguish pep-
tides that shared upward pointing amino acids but had different
I-Ab anchors as described for TCRs restricted by other MHC
molecules (Kersh et al., 2001; Stewart-Jones et al., 2012). The
2W109:I-Ab-specific T cells that could not recognize the related
2W:I-Ab ligand fell in this category. It is unlikely that these TCRs
directly recognized the anchor amino acids because their side
chains probably do not protrude from the groove of the I-Ab
molecule (Zhu et al., 2003). Rather, it is likely that the different
anchor amino acids in the two peptides produce two subtly
different conformations of the identical TCR contact amino
acids. B6 mice have T cells with TCRs that can distinguish the
two conformations and others that cannot. Act-2W mice lacked
the cross-reactive T cells, presumably because of clonal deletion
on 2W:I-Ab complexes, but retained the ones specific for the
conformation of TCR contacts that depends on the 2W109
MHCII anchors. It is therefore not surprising that changes toidin-PE (x axis) tetramer staining for CD4+ T cells from spleen and lymph nodes
d circles) orAct-2W (open circles) mice that bound 2W:I-Ab tetramer only (upper
oth 2W:I-Ab and 2W109:I-Ab tetramers (upper right quadrants in C) following
e depicted results were from one experiment, which was representative of two
s at the indicated positions were tested as stimulators of 2W109-primed CD4+
percentage of the response to the 2W109 peptide was determined by dividing
r of spots stimulated by the 2W109 peptide and multiplying by 100. The bars
ents.
centage reduction of response to the parent peptide by alanine substitutions at
esents the mean from Figure 1C for an individual peptide and the x axis value
ouse peptides predicted to bind I-Ab andmatch each of the foreign peptides in
8). For each point, the y axis value represents the mean from Figure 1C for an
ptions about linearity, also revealed a significant correlation between these
homologs was removed from the analysis (p = 0.02).
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Figure 5. Small p:MHCII-Specific T Cell Populations Are Composed
of Cells with Low-Affinity TCRs
(A) Mean fluorescence intensity (MFI) for I-Ab tetramer staining of naive CD4+
T cells from the indicated mice (***p < 0.0001, n.s. = not significant). The
depicted results were pooled from two independent experiments.
(B) Contour plots of CD4+ T cells from spleen and draining lymph nodes of B6
mice 14 days after priming with 10 mg of the indicated peptide emulsified inany of the anchor amino acids negated the reactivity of these
T cells.
Several pieces of evidence indicated that naive p:I-Ab-spe-
cific T cell populations of small size experienced extensive
clonal deletion. Like the 2W109:I-Ab-specific T cells that sur-
vived clonal deletion in Act-2W mice, the cells in the small
populations were sensitive to MHCII anchor substitutions and
expressed lower-affinity TCRs. These observations fit with
work showing that T cells that develop under conditions of
minimal clonal deletion have highly cross-reactive TCRs (Hu-
seby et al., 2005) and T cells that survive clonal deletion
have lower affinity TCRs (Moon et al., 2011; Zehn and Bevan,
2006). Thus, large naive populations may be especially valu-
able to the host because they generate large numbers of
effector cells expressing high affinity TCRs that are more
tolerant to MHC-anchor variants of peptides produced by
pathogens.
The inverse correlation between the number of cells in a
foreign peptide-specific naive T cell population and the number
of predicted self peptides with similar TCR contacts is evidence
that small populations are pared by deletion of clones with self
p:MHC-specific TCRs. It is important to note, however, that
this correlation was relatively weak. One reason for this could
be that peptides that share TCR contact amino acids but have
different MHCII anchor amino acids are often, but not always,
recognized by the same TCRs. This uncertainty means that
some of the mouse peptides that were predicted to cause nega-
tive selection probably do not. Another reason could be that
many of the predicted mouse peptides are in parent proteins
that are not expressed by thymic antigen-presenting cells or
are not processed correctly to release the peptide. Additionally,
other factors such as the chemistry of TCR contact amino acids
likely influence naive cell population size (Chu et al., 2010; Turner
et al., 2005).
Our findings might also be relevant for certain forms of auto-
immunity caused by tissue-restricted self peptides. We found
that one such peptide from MOG was recognized by a large
naive T cell population. The number of MOG:I-Ab-specific
T cells might be even larger than described here because
some cells with low-affinity TCRs are probably not detected by
p:MHCII tetramer staining (Sabatino et al., 2011). The large
size of the MOG:I-Ab-specific T cell population is consistent
with earlier work (Ben-Nun et al., 2006) indicating that it experi-
ences a low degree of clonal deletion. This might be the case
because MOG or other mouse peptides with the same TCR con-
tact amino acids are not abundantly displayed by I-Ab on thymic
antigen-presenting cells. The MOG:I-Ab-specific T cell popula-
tion might be especially prone to causing autoimmunity because
its large size increases the likelihood that some if itsmemberswillCFA enriched with the indicated p:I-Ab tetramers labeled with streptavidin-PE
or streptavidin-APC.
(C) Histogram overlays of 2W109:I-Ab streptavidin-PE or FliC:I-Ab streptavidin-
PE tetramer binding for cells from the upper right quadrants of (B).
(D) Linear regression analysis of the log10 naive cell number versus the tetramer
MFI for different p:I-Ab-specific populations from peptide-primed B6 mice.
Each point represents values for an individual peptide. For each point, the
y axis value represents the mean from Figure 1C for an individual peptide and
the x axis value the mean for that peptide from two independent experiments.
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Figure 6. TCR Cross-Reactivity for Foreign Peptides Similar to MOG:I-Ab Can Elicit EAE
(A) Contour plots of double tetramer staining (left) or CD44 expression (right) for CD4+ T cells from spleen and lymph nodes from individual unimmunized B6 mice
following enrichment with MOG:I-Ab tetramers labeled with streptavidin-PE (x axis) or streptavidin-APC (y axis).
(B) Total number of MOG:I-Ab double tetramer-binding CD4+ T cells in individual unimmunized mice from two independent experiments. Horizontal bar indicates
the mean.
(C) Contour plots of clonal expansion and CD44 expression by MOG:I-Ab-specific cells 14 days after subcutaneous priming with 10 mg of the indicated peptides
emulsified in CFA.
(D) Average number of MOG:I-Ab+ CD4+ T cells after injection of 10 mg of the indicated peptides (±SEM, n = 3 mice/group). The depicted results were from one
experiment, which was representative of another.
(E) EAE course after subcutaneous injection of 100 mg of the peptides indicated in (D). The depicted results show mean disease score values (n = 5) for each
peptide from one experiment, which was representative of another.be activated by a microbial mimic peptide. A similar situation
might exist for humans as it has been shown that several micro-
bial peptides stimulated myelin basic protein peptide:HLA-D
specific T cell clones (Birnbaum et al., 2014; Wucherpfennig104 Immunity 42, 95–107, January 20, 2015 ª2015 Elsevier Inc.and Strominger, 1995). These studies suggest that a better un-
derstanding of TCR cross-reactivity and negative selection
might make it possible to identify the infections that trigger
autoimmunity.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6 (B6) mice were purchased from the Jackson Laboratory or the
National Cancer Institute Mouse Repository. Act-2W (Moon et al., 2011)
mice were bred in our facilities. All mice were housed in specific pathogen-
free conditions at the University of Minnesota, and all experiments were con-
ducted in accordance with institutional and federal guidelines.
p:MHCII Tetramer Production
pRMHa-3 vectors containing the alpha and beta chains of I-Ab under the con-
trol of the metallothionein promoter were constructed as previously described
(Moon et al., 2007). Sequences encoding antigenic peptides (shown in Table 1)
were fused to the N terminus of the I-Ab beta chain via a flexible polyglycine
linker. Tetramers were produced in insect cells as previously described
(Moon et al., 2007) with the exception that in some cases biotinylated p:I-Ab
monomers were purified on a Pierce Monomeric Avidin UltraLink Resin
(Thermo Scientific). Biotinylated p:I-Ab monomers were used to make tetra-
mers with streptavidin-phycoerythrin (PE) or streptavidin-allophycocyanin
(APC) (Prozyme).
Cell Enrichment and Flow Cytometry
Single cell suspensions were prepared from spleen and lymph nodes. Staining
with p:I-Ab-streptavidin-PE and p:I-Ab-streptavidin-APC tetramers was for 1 hr
at room temperature. Anti-PE and anti-APC magnetic beads were then added
and bead-bound cells were enriched as previously described (Moon et al.,
2007; Tubo et al., 2013). Cells contained in the bound fraction were stained
on ice with antibodies specific for cell surface molecules and analyzed on an
LSR II or Fortessa (Becton Dickinson) flow cytometer. Data were analyzed
with FlowJo software.
Peptides
Peptides used for immunization or ELISPOT were purchased from Genscript.
The peptides were 11 amino acids long with the putative nonamer core in the
middle. The nonamer core sequences are shown Table 1 or the relevant fig-
ures. Peptides were emulsified in CFA and 0.05 ml of emulsion containing
10 mg of peptide was injected subcutaneously at the base of the tail.
ELISPOT
Mice were immunized by injection of 10 mg of peptide or pools of peptides
emulsified in CFA, as described above. Two weeks later, CD4+ T cells were
isolated from the draining inguinal and para-aortic lymph nodes and purified
by positive selection with anti-CD4 magnetic beads (Miltenyi Biotec). The cells
were cultured for 24 hr with B6 splenocytes and candidate peptides at a final
concentration of 20 mM and analyzed for the presence of IFN-g-producing
cells by ELISPOT. The ELISPOT assay was adapted from a published protocol
(Streeck et al., 2009) and a commercially available kit (MerckMillipore). Individ-
ual peptides were assayed in triplicate.
Alanine Scanning Approach
Single alanine substitutions were made at P-1 to P10 of test peptides. In cases
where A was in the native sequence, V was substituted, with the exception of
P4 or P6, where P was substituted. This was to avoid shifting the I-Ab-binding
register because P is a preferred amino acid at P4 and P6 based on the I:Ab-
binding matrix (Zhu et al., 2003). The peptides were assayed by ELISPOT as
described above. The results were analyzed using the publicly available script
‘‘heatmap.2’’ available for the statistical analysis program ‘‘R.’’
Identification of Bacterial Peptides with the Same TCR Contact
Amino Acids as 2W, GP66, LLO, 3K, or MOG Peptides
The set of 1,632 complete bacterial proteomes was downloaded in fasta
format from Uniprot (www.uniprot.org) using the publicly available batch
retrieval perl script. Each of these proteomes was then parsed into all possible
nine amino acid substrings (P1 to P9) and I-Ab-binding scores were generated
based on a published matrix (Zhu et al., 2003). The top 1% of predicted I-Ab-
binding peptides from each bacterial proteome were then screened against
2W, GP66, LLO, 3K, or MOG for overlap at amino acid positions 2, 5, 7, and
8 using custom C++ scripts.Identification of Mouse Peptides with the Same TCR Contact Amino
Acids as Known Immunogenic Peptides
The Mus musculus proteome was downloaded from the NCBI website
(ftp://ftp.ncbi.nlm.nih.gov/genomes/M_musculus/protein/protein.fa.gz). All
possible nine amino acid substrings were extracted from these peptide
sequences and each substring was given an I-Ab-binding score based on a
published matrix (Zhu et al., 2003). The top 5% of predicted I-Ab-binding
mouse peptideswere then screened against the sequences of the foreign pep-
tides shown in Table 1 using custom C++ scripts to identify mouse peptides
that shared 4 of 5 amino acids at positions 2, 3, 5, 7, and 8 with the foreign
peptides.
EAE Induction and Clinical Evaluation
Mice were immunized subcutaneously with 100 mg of MOG peptide or 11
amino acid versions of homologous bacterial peptides emulsified in CFA con-
taining Mycobacterium tuberculosis. In addition, the mice received 200 ng of
pertussis toxin (List Biological Laboratories) intravenously on the day of, and
2 days after, peptide immunization. Individual animals were graded according
to clinical severity as follows: grade 0, no abnormality; grade 1, limp tail; grade
2, limp tail and hind limb weakness; grade 3, partial hind limb paralysis; grade
4, complete hind limb paralysis; as previously described (Fife et al., 2000).
Statistical Analysis
Two-tailed Student’s t tests, linear regressions, and Spearman’s Rho test were
performed with Prism (Graphpad) software.
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